Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Pogledi
• 08/09/23
0
0
Ugraditi
administrator
Pretplatnici
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari